<DOC>
	<DOCNO>NCT00198419</DOCNO>
	<brief_summary>The objective study rule great 10 % incidence hypersensitivity Vitrase follow single intradermal injection 3 USP unit Vitrase . Less equal 10 % hypersensitivity response consider acceptable .</brief_summary>
	<brief_title>Hypersensitivity Reaction Vitrase ( Ovine Hyaluronidase )</brief_title>
	<detailed_description />
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Drug Hypersensitivity</mesh_term>
	<criteria>Avoid disallow med throughout study Known hypersensitivity hyaluronidase and/or bee sting Atopic individual assess med history Topical/systemic corticosteroid within 30 day Concurrent use antihistamine antiinflammatory study Active chronic disease likely affect immune function History alcohol/drug abuse within 6 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
</DOC>